Perrigo Stock Price, News & Analysis (NYSE:PRGO)

$91.69 0.09 (0.10 %)
(As of 01/19/2018 07:55 AM ET)
Previous Close$91.60
Today's Range$89.37 - $91.74
52-Week Range$63.68 - $92.75
Volume1.04 million shs
Average Volume987,000 shs
Market Capitalization$12.90 billion
P/E Ratio-10.01
Dividend Yield0.70%
Beta0.7

About Perrigo (NYSE:PRGO)

Perrigo logoPerrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri. Its businesses include Consumer Healthcare, Nutritionals, Rx Pharmaceuticals, API, Life Sciences and Other Businesses. The Company offers Healthcare Products across a range of product categories primarily in the United States, the United Kingdom, Mexico, Israel and Australia. In February 2014, the Company announced that it has acquired a basket of value-brand OTC products sold in Australia and New Zealand from Aspen Global Inc.

Receive PRGO News and Ratings via Email

Sign-up to receive the latest news and ratings for PRGO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drug Related Products
Sub-IndustryPharmaceuticals
SectorMedical
SymbolNYSE:PRGO
CUSIP71429010
Phone353-1709-4000

Debt

Debt-to-Equity Ratio0.54%
Current Ratio1.72%
Quick Ratio1.24%

Price-To-Earnings

Trailing P/E Ratio-10.0098253275109
Forward P/E Ratio18.79
P/E Growth1.93

Sales & Book Value

Annual Sales$5.28 billion
Price / Sales2.45
Cash Flow$8.10 per share
Price / Cash11.32
Book Value$41.55 per share
Price / Book2.21

Profitability

Trailing EPS($9.16)
Net Income$-4,012,800,000.00
Net Margins-26.28%
Return on Equity11.60%
Return on Assets5.44%

Miscellaneous

Employees12,800
Outstanding Shares140,840,000

Perrigo (NYSE:PRGO) Frequently Asked Questions

What is Perrigo's stock symbol?

Perrigo trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRGO."

How often does Perrigo pay dividends? What is the dividend yield for Perrigo?

Perrigo announced a quarterly dividend on Thursday, November 2nd. Shareholders of record on Friday, December 1st will be paid a dividend of $0.16 per share on Tuesday, December 19th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.70%. The ex-dividend date of this dividend is Thursday, November 30th. View Perrigo's Dividend History.

How were Perrigo's earnings last quarter?

Perrigo Company (NYSE:PRGO) released its quarterly earnings data on Thursday, November, 9th. The company reported $1.39 EPS for the quarter, beating analysts' consensus estimates of $1.11 by $0.28. The company earned $1.22 billion during the quarter, compared to analysts' expectations of $1.17 billion. Perrigo had a positive return on equity of 11.60% and a negative net margin of 26.28%. Perrigo's revenue was down 2.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.65 EPS. View Perrigo's Earnings History.

When will Perrigo make its next earnings announcement?

Perrigo is scheduled to release their next quarterly earnings announcement on Monday, February, 26th 2018. View Earnings Estimates for Perrigo.

What guidance has Perrigo issued on next quarter's earnings?

Perrigo updated its FY17 earnings guidance on Thursday, November, 9th. The company provided earnings per share (EPS) guidance of $4.80-4.95 for the period, compared to the Thomson Reuters consensus estimate of $4.58.

Where is Perrigo's stock going? Where will Perrigo's stock price be in 2018?

16 brokerages have issued 1 year price targets for Perrigo's shares. Their forecasts range from $67.00 to $125.00. On average, they expect Perrigo's stock price to reach $91.60 in the next year. View Analyst Ratings for Perrigo.

What are Wall Street analysts saying about Perrigo stock?

Here are some recent quotes from research analysts about Perrigo stock:

  • 1. Cantor Fitzgerald analysts commented, "CDC released updated data on the 2017-2018 Influenza Season for Week 46, ending 11/18/17 (https://www.cdc.gov/flu/weekly/)." (11/28/2017)
  • 2. Canaccord Genuity analysts commented, "Date and time of first dissemination: May 22, 2017, 23:13 ET Date and time of production: May 22, 2017, 22:26 ET Target Price / Valuation Methodology: Perrigo Company – PRGO Discounted cash flow analysis supports an $86 valuation for PRGO shares Our discounted cash flow (DCF) analysis leads us to a price target of $86/share for PRGO. Our DCF considers our estimates through 2021, low-single-digit growth through 2033 and zero terminal growth thereafter. In addition, we expect Perrigo’s margin structure to remain somewhat consistent with our 2021 estimates." (5/22/2017)
  • 3. Deutsche Bank AG analysts commented, "We updated our model to reflect PRGO's divestiture of the Tysabri royalty stream to Royalty Pharma, which the company expects to complete this month, and preliminary assumptions for de-leveraging with the proceeds. The net effect of these changes was EPS dilution of ~15-20% over 2017-21 and a reduction in our DCF-derived PT to $87 (from $93), as our prior model reflected more value for the Tysabri royalty stream (~$3bn) relative to the upfront payment of $2.2bn. We have not factored in the potential sales-based milestone payments of $650mn, which could add ~$4/share to the theoretical DCF value if they hit. We continue to view PRGO as a unique asset with good value creation potential over the longer term, and are maintaining our Buy rating. Solid execution in the coming quarters will be critical for the stock, in our view." (3/14/2017)
  • 4. Jefferies Group LLC analysts commented, "Unaudited Q4 results were ahead of forecast. But the real story is FY17 guidance and it disappointed even after sharp cuts to Street models just 4 weeks ago. For the first time we can recall both rev & EPS will decline ' not a good story line for an OTC-focused company. Tysabri's sale helps de-lever PRGO but at the same time shrinks the EPS base by ~$2.20. Mgt continues to make moves to enhance shareholder value ' but it may take quite some time to do so." (2/28/2017)
  • 5. Royal Bank of Canada analysts commented, "While we expected a challenging 2017 guide, it was worse than we anticipated and came with an unexpected CFO departure. The strategic review around whether to sell Rx/generics will linger, limiting visibility but the conundrum is that we do not see upside in either scenario. We remain on the sidelines with target down to $68. Several additional thoughts after speaking with management this evening." (2/28/2017)

Who are some of Perrigo's key competitors?

Who owns Perrigo stock?

Perrigo's stock is owned by many different of retail and institutional investors. Top institutional investors include Schwab Charles Investment Management Inc. (0.36%), Bank of Montreal Can (0.16%), Moon Capital Management LLC (0.03%), State of Alaska Department of Revenue (0.02%), Exxonmobil Investment Management Inc. TX (0.01%) and Nisa Investment Advisors LLC (0.01%). Company insiders that own Perrigo stock include Gary K Kunkle Jr, Geoffrey M Parker, Herman Morris Jr, Jeffrey Needham, John Wesolowski, Judy L Brown, Michael J Jandernoa, Sharon Kochan, Thomas Farrington and Todd W Kingma. View Institutional Ownership Trends for Perrigo.

Who sold Perrigo stock? Who is selling Perrigo stock?

Perrigo's stock was sold by a variety of institutional investors in the last quarter, including Gofen & Glossberg LLC IL, Exxonmobil Investment Management Inc. TX, Gateway Investment Advisers LLC, Moon Capital Management LLC and Livforsakringsbolaget Skandia Omsesidigt. Company insiders that have sold Perrigo company stock in the last year include Jeffrey Needham, John Wesolowski, Sharon Kochan, Thomas Farrington and Todd W Kingma. View Insider Buying and Selling for Perrigo.

Who bought Perrigo stock? Who is buying Perrigo stock?

Perrigo's stock was bought by a variety of institutional investors in the last quarter, including Bank of Montreal Can, Schwab Charles Investment Management Inc., State of Alaska Department of Revenue, Oakbrook Investments LLC, E&G Advisors LP, Contravisory Investment Management Inc. and Nisa Investment Advisors LLC. Company insiders that have bought Perrigo stock in the last two years include Geoffrey M Parker and John Wesolowski. View Insider Buying and Selling for Perrigo.

How do I buy Perrigo stock?

Shares of Perrigo can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Perrigo's stock price today?

One share of Perrigo stock can currently be purchased for approximately $91.69.

How big of a company is Perrigo?

Perrigo has a market capitalization of $12.90 billion and generates $5.28 billion in revenue each year. The company earns $-4,012,800,000.00 in net income (profit) each year or ($9.16) on an earnings per share basis. Perrigo employs 12,800 workers across the globe.

How can I contact Perrigo?

Perrigo's mailing address is TREASURY BUILDING LOWER GRAND CANAL STREET, DUBLIN L2, 49010. The company can be reached via phone at 353-1709-4000 or via email at [email protected]


MarketBeat Community Rating for Perrigo (PRGO)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  524 (Vote Outperform)
Underperform Votes:  500 (Vote Underperform)
Total Votes:  1,024
MarketBeat's community ratings are surveys of what our community members think about Perrigo and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Perrigo (NYSE:PRGO) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyHoldHold
Consensus Rating Score: 2.502.532.402.20
Ratings Breakdown: 0 Sell Rating(s)
8 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
7 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
7 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
8 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $91.60$91.71$87.77$82.00
Price Target Upside: 0.81% upside6.03% upside0.27% upside11.01% upside

Perrigo (NYSE:PRGO) Consensus Price Target History

Price Target History for Perrigo (NYSE:PRGO)

Perrigo (NYSE:PRGO) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/17/2018Canaccord GenuityReiterated RatingBuy$100.00LowView Rating Details
1/12/2018Cantor FitzgeraldSet Price TargetBuy$107.00LowView Rating Details
1/2/2018Leerink SwannInitiated CoverageMkt Perform -> Market Perform$90.00LowView Rating Details
12/8/2017ArgusUpgradeHold -> Buy$93.00MediumView Rating Details
12/4/2017BarclaysBoost Price TargetOverweight$93.00MediumView Rating Details
11/10/2017Jefferies GroupReiterated RatingHold$81.00N/AView Rating Details
11/10/2017Wells Fargo & CoBoost Price TargetMarket Perform$90.00N/AView Rating Details
11/10/2017Morgan StanleyBoost Price TargetEqual Weight$79.00 -> $92.00N/AView Rating Details
11/10/2017Royal Bank of CanadaUpgradeUnderperform -> Sector Perform$64.00 -> $86.00N/AView Rating Details
10/2/2017OppenheimerInitiated CoverageBuy$88.00LowView Rating Details
9/14/2017Deutsche BankBoost Price TargetBuy$88.00 -> $95.00LowView Rating Details
9/7/2017CIBCInitiated CoverageOutperform -> Outperform$88.00LowView Rating Details
8/11/2017Stifel NicolausReiterated RatingHoldLowView Rating Details
8/11/2017Goldman Sachs GroupUpgradeSell -> Neutral$66.00 -> $79.00MediumView Rating Details
4/22/2017B. RileyReiterated RatingNeutral$67.00MediumView Rating Details
2/28/2017GuggenheimReiterated RatingBuy$125.00N/AView Rating Details
11/10/2016JPMorgan Chase & Co.Set Price TargetHold$95.00N/AView Rating Details
11/11/2016Bank of AmericaUpgradeUnderperform -> NeutralN/AView Rating Details
8/11/2016Northland SecuritiesDowngradeOutperform -> Market Perform$123.00 -> $94.00N/AView Rating Details
6/17/2016BTIG ResearchReiterated RatingNeutralN/AView Rating Details
6/15/2016Raymond James FinancialReiterated RatingHoldN/AView Rating Details
2/22/2016William BlairReiterated RatingMarket PerformN/AView Rating Details
(Data available from 1/19/2016 forward)

Earnings

Perrigo (NYSE:PRGO) Earnings History and Estimates Chart

Earnings by Quarter for Perrigo (NYSE:PRGO)

Perrigo (NYSE PRGO) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/26/2018$1.23N/AView Earnings Details
11/9/2017Q3 17$1.11$1.39$1.17 billion$1.22 billionViewN/AView Earnings Details
8/10/20176/30/2017$0.94$1.22$1.18 billion$1.24 billionViewN/AView Earnings Details
5/30/2017Q1 17$0.99$1.05$1.19 billion$1.19 billionViewN/AView Earnings Details
5/22/201712/31/2016$1.76$1.24$1.39 billion$1.33 billionViewN/AView Earnings Details
11/10/2016Q316$1.58$1.65$1.28 billion$1.40 billionViewN/AView Earnings Details
8/10/2016Q216$1.98$1.93$1.43 billion$1.48 billionViewListenView Earnings Details
5/12/2016Q116$1.75$1.75$1.35 billion$1.34 billionViewListenView Earnings Details
2/18/2016Q415$1.93$1.80$1.46 billion$1.42 billionViewListenView Earnings Details
10/22/2015Q3$1.73$1.76$1.42 billion$1.34 billionViewListenView Earnings Details
8/5/2015Q2$1.96$2.18$1.52 million$1.53 millionViewN/AView Earnings Details
4/21/2015Q315$1.78$1.85$1.10 billion$1.05 billionViewN/AView Earnings Details
2/5/2015Q215$1.79$1.82$1.09 billion$1.07 billionViewN/AView Earnings Details
11/6/2014Q115$1.44$1.40$997.90 million$951.50 millionViewN/AView Earnings Details
8/14/2014Q414$1.55$1.74$1.09 billion$1.14 billionViewN/AView Earnings Details
5/7/2014Q314$1.51$1.31$1.07 billion$1,000.00 millionViewN/AView Earnings Details
2/6/2014Q214$1.59$1.87$996.68 million$979.00 millionViewN/AView Earnings Details
10/31/2013Q114$1.40$1.52$900.10 million$933.00 millionViewN/AView Earnings Details
8/15/2013Q4 2013$1.56$1.57$999.08 million$967.20 millionViewN/AView Earnings Details
5/7/2013Q3 2013$1.44$1.42$935.44 million$919.83 millionViewN/AView Earnings Details
2/1/2013Q2 2013$1.31$1.36$881.84 million$882.96 millionViewN/AView Earnings Details
11/7/2012Q113$1.24$1.27$825.83 million$769.80 millionViewN/AView Earnings Details
8/16/2012$1.27$1.28ViewN/AView Earnings Details
5/8/2012$1.22$1.41ViewN/AView Earnings Details
2/7/2012$1.15$1.20ViewN/AView Earnings Details
10/27/2011$1.06$1.10ViewN/AView Earnings Details
8/16/2011$0.97$1.02ViewN/AView Earnings Details
5/3/2011$0.97$1.07ViewN/AView Earnings Details
2/1/2011$0.95$1.05ViewN/AView Earnings Details
11/2/2010Q3 2010$0.77$0.87ViewN/AView Earnings Details
8/12/2010Q2 2010$0.68$0.71ViewN/AView Earnings Details
4/29/2010Q1 2010$0.63$0.76ViewN/AView Earnings Details
2/2/2010Q4 2009$0.66$0.70ViewN/AView Earnings Details
11/2/2009Q3 2009$0.49$0.66ViewN/AView Earnings Details
8/18/2009Q2 2009$0.46$0.50ViewN/AView Earnings Details
5/7/2009Q1 2009$0.45$0.51ViewN/AView Earnings Details
2/3/2009Q4 2008$0.50$0.46ViewN/AView Earnings Details
11/6/2008Q3 2008$0.42$0.41ViewN/AView Earnings Details
8/18/2008Q2 2008$0.40$0.39ViewN/AView Earnings Details
5/6/2008Q1 2008$0.42$0.44ViewN/AView Earnings Details
2/5/2008Q4 2007$0.34$0.36ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Perrigo (NYSE:PRGO) Earnings Estimates

2018 EPS Consensus Estimate: $5.40
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181$1.13$1.13$1.13
Q2 20181$1.34$1.34$1.34
Q3 20181$1.44$1.44$1.44
Q4 20181$1.49$1.49$1.49
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Perrigo (NYSE:PRGO) Dividend Information

Most Recent Dividend:12/19/2017
Annual Dividend:$0.64
Dividend Yield:0.70%
Dividend Growth:15.10% (3 Year Average)
Payout Ratio:-6.99% (Trailing 12 Months of Earnings)
13.11% (Based on This Year's Estimates)
11.92% (Based on Next Year's Estimates)
Track Record:15 Years of Consecutive Dividend Growth
Frequency:Quarterly Dividend
Dividend Payments by Quarter for Perrigo (NYSE:PRGO)

Perrigo (NYSE:PRGO) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
11/2/2017quarterly$0.160.77%11/30/201712/1/201712/19/2017
8/8/2017Quarterly$0.160.96%8/23/20178/25/20179/12/2017
5/3/2017quarterly$0.160.88%5/24/20175/26/20176/13/2017
2/21/2017quarterly$0.160.76%3/1/20173/3/20173/21/2017
11/8/2016quarterly$0.150.69%11/22/201611/25/201612/13/2016
8/2/2016quarterly$0.150.62%8/24/20168/26/20169/13/2016
4/26/2016$0.155/25/20165/27/20166/14/2016
4/26/2016quarterly$0.155/25/20165/27/20166/14/2016
2/16/2016quarterly$0.152/24/20162/26/20163/15/2016
11/4/2015quarterly$0.1311/24/201511/27/201512/15/2015
8/12/2015quarterly$0.138/26/20158/28/20159/15/2015
4/29/2015quarterly$0.130.27%5/27/20155/29/20156/16/2015
1/27/2015quarterly$0.132/25/20152/27/20153/17/2015
11/3/2014quarterly$0.110.26%11/27/201411/28/201412/16/2014
8/13/2014quarterly$0.110.28%8/27/20148/29/20149/16/2014
4/28/2014quarterly$0.110.29%5/28/20145/30/20146/17/2014
1/29/2014quarterly$0.110.27%2/26/20142/28/20143/18/2014
11/6/2013quarterly$0.090.25%11/26/201311/29/201312/17/2013
8/14/2013quarterly$0.090.29%8/28/20138/30/20139/17/2013
5/2/2013quarterly$0.090.3%5/29/20135/31/20136/18/2013
1/31/2013quarterly$0.090.34%2/27/20133/1/20133/19/2013
(Data available from 1/1/2013 forward)

Insider Trades

Perrigo (NYSE PRGO) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 6.90%
Institutional Ownership Percentage: 83.22%
Insider Trades by Quarter for Perrigo (NYSE:PRGO)
Institutional Ownership by Quarter for Perrigo (NYSE:PRGO)

Perrigo (NYSE PRGO) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/28/2018Todd W KingmaVPSell1,500$88.52$132,780.0019,565View SEC Filing  
12/28/2017Todd W KingmaVPSell1,500$88.52$132,780.0019,565View SEC Filing  
12/14/2017John WesolowskiEVPBuy700$85.80$60,060.00View SEC Filing  
12/7/2017John WesolowskiEVPSell450$83.09$37,390.50View SEC Filing  
11/29/2017John WesolowskiEVPSell388$87.20$33,833.60248View SEC Filing  
11/16/2017Thomas FarringtonEVPSell213$87.26$18,586.383,347View SEC Filing  
9/12/2017Jeffrey NeedhamEVPSell3,595$89.49$321,716.5510,118View SEC Filing  
9/7/2017Sharon KochanEVPSell318$81.36$25,872.4810,231View SEC Filing  
8/31/2017Sharon KochanEVPSell1,500$79.03$118,545.0010,349View SEC Filing  
8/30/2017Thomas FarringtonEVPSell616$76.90$47,370.402,724View SEC Filing  
8/18/2017Thomas FarringtonEVPSell865$78.40$67,816.002,870View SEC Filing  
11/25/2016Judy L BrownEVPSell2,097$89.44$187,555.6810,007View SEC Filing  
11/21/2016Geoffrey M ParkerDirectorBuy2,500$88.75$221,875.00View SEC Filing  
10/24/2016Judy L BrownEVPSell2,092$90.42$189,158.6412,104View SEC Filing  
9/26/2016Judy L BrownCFOSell2,096$96.76$202,808.9614,196View SEC Filing  
9/26/2016Thomas FarringtonEVPSell1,110$96.76$107,403.602,970View SEC Filing  
9/9/2016Gary K Kunkle JrDirectorSell5,814$89.95$522,969.3031,501View SEC Filing  
9/8/2016Herman Morris JrDirectorSell1,073$90.96$97,600.0810,425View SEC Filing  
8/26/2016Judy L BrownEVPSell2,095$88.28$184,946.6016,292View SEC Filing  
4/13/2016Judy L BrownCFOSell2,776$126.22$350,386.7213,924View SEC Filing  
3/18/2016Michael J JandernoaDirectorSell761$128.29$97,628.698,611View SEC Filing  
3/2/2016Sharon KochanEVPSell1,490$125.28$186,667.205,883View SEC Filing  
2/24/2016Judy L BrownCFOSell2,776$123.73$343,474.4813,924View SEC Filing  
1/6/2016Judy L. BrownCFOSell27,737$142.41$3,950,026.1712,429View SEC Filing  
12/28/2015Joseph C. PapaChairmanSell10,183$147.07$1,497,613.81118,515View SEC Filing  
8/25/2015John T. HendricksonEVPSell1,737$181.37$315,039.69View SEC Filing  
8/25/2015Todd W. KingmaVPSell1,715$181.37$311,049.5510,320View SEC Filing  
8/24/2015John T. HendricksonEVPSell4,468$177.68$793,874.241,737View SEC Filing  
4/29/2015Todd W KingmaVPSell1,700$190.27$323,459.00View SEC Filing  
4/14/2015John T HendricksonEVPSell8,800$200.27$1,762,376.00View SEC Filing  
4/13/2015Todd W KingmaVPSell1,300$198.44$257,972.00View SEC Filing  
3/13/2015Jatin ShahSVPSell2,000$165.50$331,000.00View SEC Filing  
10/1/2014Judy L BrownCFOSell3,515$150.72$529,780.80View SEC Filing  
9/3/2014Sharon KochanEVPSell1,116$150.00$167,400.00View SEC Filing  
9/3/2014Todd W KingmaVPSell2,250$149.65$336,712.50View SEC Filing  
9/2/2014Judy L BrownCFOSell3,515$149.32$524,859.80View SEC Filing  
9/2/2014Thomas FarringtonVPSell1,741$150.36$261,776.76View SEC Filing  
8/27/2014Michael Robert StewartVPSell4,519$148.78$672,336.82View SEC Filing  
8/26/2014Jeffrey NeedhamVPSell10,205$148.54$1,515,850.70View SEC Filing  
8/26/2014Judy L BrownCFOSell4,827$148.87$718,595.49View SEC Filing  
8/25/2014John T HendricksonEVPSell2,533$148.44$375,998.52View SEC Filing  
5/15/2014Ran GottfriedDirectorSell1,000$131.25$131,250.0012,159View SEC Filing  
3/24/2014Joseph PapaChairmanSell10,000$157.72$1,577,200.0095,500View SEC Filing  
1/16/2014Joseph PapaChairmanSell5,000$157.59$787,950.0096,655View SEC Filing  
12/12/2013Gary CohenDirectorSell4,632$152.52$706,472.6411,868View SEC Filing  
12/12/2013Joseph PapaChairmanSell15,000$150.12$2,251,800.0096,655View SEC Filing  
12/9/2013Michael JandernoaDirectorSell128,620$155.30$19,974,686.00868View SEC Filing  
11/25/2013Louis YuVPSell2,292$155.51$356,428.928,548View SEC Filing  
11/21/2013Judy BrownCFOSell9,988$154.74$1,545,543.127,445View SEC Filing  
11/20/2013John HendricksonEVPSell8,400$152.80$1,283,520.00View SEC Filing  
11/4/2013Ran GottfriedDirectorSell2,275$143.36$326,144.0011,609View SEC Filing  
9/24/2013Joseph PapaChairmanSell15,000$124.60$1,869,000.00116,655View SEC Filing  
9/18/2013John HendricksonEVPSell2,161$125.00$270,125.00View SEC Filing  
9/11/2013Michael Robert StewartVPSell5,063$123.37$624,622.31View SEC Filing  
9/9/2013Louis YuVPSell1,852$124.11$229,851.72View SEC Filing  
9/6/2013John T HendricksonEVPSell1,000$123.46$123,460.00View SEC Filing  
9/4/2013John T HendricksonEVPSell2,000$123.92$247,840.00View SEC Filing  
9/3/2013Judy BrownCFOSell2,500$122.07$305,175.0017,433View SEC Filing  
8/30/2013Jeffrey NeedhamVPSell6,585$120.47$793,294.955,199View SEC Filing  
8/29/2013Sharon KochanVPSell3,467$120.98$419,437.665,541View SEC Filing  
8/27/2013Joseph PapaChairmanSell15,000$117.64$1,764,600.00118,455View SEC Filing  
8/26/2013John HendricksonEVPSell2,099$119.15$250,095.85View SEC Filing  
8/26/2013Judy BrownCFOSell3,424$119.28$408,414.7217,433View SEC Filing  
8/20/2013John HendricksonEVPSell1,676$118.56$198,706.56View SEC Filing  
8/20/2013Judy BrownCFOSell2,804$118.58$332,498.3217,433View SEC Filing  
8/20/2013Thomas FarringtonVPSell1,658$119.86$198,727.881,040View SEC Filing  
8/16/2013Todd KingmaVPSell1,250$120.00$150,000.0017,065View SEC Filing  
7/19/2013Todd W KingmaVPSell1,250$129.37$161,712.50View SEC Filing  
7/11/2013Joseph C PapaChairmanSell10,000$128.54$1,285,400.00View SEC Filing  
7/9/2013John T HendricksonEVPSell2,161$125.00$270,125.00View SEC Filing  
6/14/2013Joseph C PapaChairmanSell10,000$118.39$1,183,900.00View SEC Filing  
6/14/2013Todd W KingmaVPSell1,250$118.00$147,500.00View SEC Filing  
6/4/2013Judy L BrownCFOSell2,500$116.38$290,950.00View SEC Filing  
5/14/2013Sharon KochanVPSell2,647$119.64$316,687.085,492View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Perrigo (NYSE PRGO) News Headlines

Source:
DateHeadline
Zacks: Analysts Anticipate Perrigo Company (PRGO) Will Announce Quarterly Sales of $1.24 BillionZacks: Analysts Anticipate Perrigo Company (PRGO) Will Announce Quarterly Sales of $1.24 Billion
www.americanbankingnews.com - January 15 at 2:36 AM
Zacks: Brokerages Anticipate Perrigo Company (PRGO) Will Announce Earnings of $1.23 Per ShareZacks: Brokerages Anticipate Perrigo Company (PRGO) Will Announce Earnings of $1.23 Per Share
www.americanbankingnews.com - January 13 at 11:32 PM
Perrigo (PRGO) PT Set at $107.00 by Cantor FitzgeraldPerrigo (PRGO) PT Set at $107.00 by Cantor Fitzgerald
www.americanbankingnews.com - January 12 at 1:26 PM
Perrigo (PRGO) Hits 52-Week High: Whats Driving the Stock?Perrigo (PRGO) Hits 52-Week High: What's Driving the Stock?
www.zacks.com - January 12 at 10:21 AM
Elagolix May Advance the Treatment Paradigm in Women’s HealthElagolix May Advance the Treatment Paradigm in Women’s Health
finance.yahoo.com - January 11 at 10:45 AM
Perrigo Trying To Close In On Key Technical BenchmarkPerrigo Trying To Close In On Key Technical Benchmark
finance.yahoo.com - January 11 at 10:45 AM
Recent Developments for MylanRecent Developments for Mylan
finance.yahoo.com - January 11 at 10:45 AM
Incoming Perrigo CEO Brings Strong Operations ExperienceIncoming Perrigo CEO Brings Strong Operations Experience
finance.yahoo.com - January 9 at 4:39 PM
S&P 500 Movers: PRGO, STX - NasdaqS&P 500 Movers: PRGO, STX - Nasdaq
www.nasdaq.com - January 8 at 4:41 PM
Perrigo (PRGO) Announces Uwe Rohrhoff As President & CEO; Effective January 15, 2018 - StreetInsider.comPerrigo (PRGO) Announces Uwe Rohrhoff As President & CEO; Effective January 15, 2018 - StreetInsider.com
www.streetinsider.com - January 8 at 4:41 PM
Perrigo Company (PRGO) Given Average Rating of "Hold" by BrokeragesPerrigo Company (PRGO) Given Average Rating of "Hold" by Brokerages
www.americanbankingnews.com - January 8 at 12:40 PM
Perrigo (PRGO) Given a $107.00 Price Target by Cantor Fitzgerald AnalystsPerrigo (PRGO) Given a $107.00 Price Target by Cantor Fitzgerald Analysts
www.americanbankingnews.com - January 5 at 1:34 PM
Equities Analysts Offer Predictions for Perrigo Companys FY2017 Earnings (PRGO)Equities Analysts Offer Predictions for Perrigo Company's FY2017 Earnings (PRGO)
www.americanbankingnews.com - January 5 at 7:42 AM
Leerink Swann Comments on Perrigo Companys Q1 2018 Earnings (PRGO)Leerink Swann Comments on Perrigo Company's Q1 2018 Earnings (PRGO)
www.americanbankingnews.com - January 4 at 10:16 AM
Perrigo Gets Tentative FDA Approval For Generic Version Of ProlensaPerrigo Gets Tentative FDA Approval For Generic Version Of Prolensa
www.nasdaq.com - January 3 at 9:35 AM
Perrigo Announces Tentative FDA Approval For The Generic Version Of Prolensa® Ophthalmic Solution 0.07%Perrigo Announces Tentative FDA Approval For The Generic Version Of Prolensa® Ophthalmic Solution 0.07%
finance.yahoo.com - January 3 at 9:35 AM
Perrigo (PRGO) Coverage Initiated by Analysts at Leerink SwannPerrigo (PRGO) Coverage Initiated by Analysts at Leerink Swann
www.americanbankingnews.com - January 2 at 5:18 PM
Perrigo To Present At The 36th Annual J.P. Morgan Healthcare ConferencePerrigo To Present At The 36th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 2 at 10:12 AM
Perrigo Company (PRGO) VP Todd W. Kingma Sells 1,500 SharesPerrigo Company (PRGO) VP Todd W. Kingma Sells 1,500 Shares
www.americanbankingnews.com - January 1 at 4:56 AM
$1.24 Billion in Sales Expected for Perrigo Company (PRGO) This Quarter$1.24 Billion in Sales Expected for Perrigo Company (PRGO) This Quarter
www.americanbankingnews.com - December 30 at 4:32 PM
Canaccord Genuity Analysts Give Perrigo (PRGO) a $100.00 Price TargetCanaccord Genuity Analysts Give Perrigo (PRGO) a $100.00 Price Target
www.americanbankingnews.com - December 29 at 11:34 PM
Todd W. Kingma Sells 1,500 Shares of Perrigo Company (PRGO) StockTodd W. Kingma Sells 1,500 Shares of Perrigo Company (PRGO) Stock
www.americanbankingnews.com - December 29 at 12:26 PM
Perrigo Company to Post FY2017 Earnings of $4.78 Per Share, Cantor Fitzgerald Forecasts (PRGO)Perrigo Company to Post FY2017 Earnings of $4.78 Per Share, Cantor Fitzgerald Forecasts (PRGO)
www.americanbankingnews.com - December 29 at 7:02 AM
 Brokerages Expect Perrigo Company (PRGO) to Post $1.23 Earnings Per Share Brokerages Expect Perrigo Company (PRGO) to Post $1.23 Earnings Per Share
www.americanbankingnews.com - December 28 at 11:02 AM
Zacks: Analysts Anticipate Perrigo Company (PRGO) Will Post Earnings of $1.23 Per ShareZacks: Analysts Anticipate Perrigo Company (PRGO) Will Post Earnings of $1.23 Per Share
www.americanbankingnews.com - December 28 at 11:02 AM
Perrigo (PRGO) Given a $107.00 Price Target at Cantor FitzgeraldPerrigo (PRGO) Given a $107.00 Price Target at Cantor Fitzgerald
www.americanbankingnews.com - December 25 at 3:48 PM
Cantor Fitzgerald Reiterates $107.00 Price Target for Perrigo (PRGO)Cantor Fitzgerald Reiterates $107.00 Price Target for Perrigo (PRGO)
www.americanbankingnews.com - December 22 at 5:26 PM
Perrigo Company (PRGO) EVP John Wesolowski Buys 700 SharesPerrigo Company (PRGO) EVP John Wesolowski Buys 700 Shares
www.americanbankingnews.com - December 19 at 9:48 PM
Perrigo Co. Plc – Value Analysis (NYSE:PRGO) : December 19, 2017Perrigo Co. Plc – Value Analysis (NYSE:PRGO) : December 19, 2017
finance.yahoo.com - December 19 at 4:33 PM
Perrigo lines up bid for Mercks consumer health unit - sourcesPerrigo lines up bid for Merck's consumer health unit - sources
finance.yahoo.com - December 14 at 5:05 PM
Perrigo preparing non-binding bid for Merck KgaAs consumer health unit -sourcesPerrigo preparing non-binding bid for Merck KgaA's consumer health unit -sources
finance.yahoo.com - December 14 at 5:05 PM
Perrigo to bid for German Mercks consumer health unit - ReutersPerrigo to bid for German Merck's consumer health unit - Reuters
seekingalpha.com - December 14 at 4:55 PM
Perrigo Company (PRGO) Given Consensus Rating of "Hold" by AnalystsPerrigo Company (PRGO) Given Consensus Rating of "Hold" by Analysts
www.americanbankingnews.com - December 14 at 2:34 PM
Perrigo Company (PRGO) EVP Sells $37,390.50 in StockPerrigo Company (PRGO) EVP Sells $37,390.50 in Stock
www.americanbankingnews.com - December 11 at 11:34 PM
Perrigo Company (PRGO) Expected to Announce Earnings of $1.23 Per SharePerrigo Company (PRGO) Expected to Announce Earnings of $1.23 Per Share
www.americanbankingnews.com - December 10 at 9:37 PM
UPDATE: Argus Upgrades Perrigo Co. (PRGO) to Buy - StreetInsider.comUPDATE: Argus Upgrades Perrigo Co. (PRGO) to Buy - StreetInsider.com
www.streetinsider.com - December 9 at 4:31 PM
Perrigo (PRGO) Upgraded at ArgusPerrigo (PRGO) Upgraded at Argus
www.americanbankingnews.com - December 8 at 9:02 PM
ETFs with exposure to Perrigo Co. Plc : December 8, 2017ETFs with exposure to Perrigo Co. Plc : December 8, 2017
finance.yahoo.com - December 8 at 4:32 PM
Analyst: Despite Industry Woes, Investigations, And Management Shake-Up, Perrigo Is A BuyAnalyst: Despite Industry Woes, Investigations, And Management Shake-Up, Perrigo Is A Buy
www.msn.com - December 8 at 10:20 AM
Perrigo Co. Plc breached its 50 day moving average in a Bearish Manner : PRGO-US : December 6, 2017Perrigo Co. Plc breached its 50 day moving average in a Bearish Manner : PRGO-US : December 6, 2017
finance.yahoo.com - December 6 at 10:36 AM
Barclays Increases Perrigo (PRGO) Price Target to $93.00Barclays Increases Perrigo (PRGO) Price Target to $93.00
www.americanbankingnews.com - December 4 at 1:04 PM
John Wesolowski Sells 388 Shares of Perrigo Company (PRGO) StockJohn Wesolowski Sells 388 Shares of Perrigo Company (PRGO) Stock
www.americanbankingnews.com - November 30 at 9:10 PM
Perrigo Company (PRGO) Ex-Dividend Date Scheduled for November 30, 2017 - NasdaqPerrigo Company (PRGO) Ex-Dividend Date Scheduled for November 30, 2017 - Nasdaq
www.nasdaq.com - November 29 at 4:49 PM
Perrigos (PRGO) "Buy" Rating Reiterated at Cantor FitzgeraldPerrigo's (PRGO) "Buy" Rating Reiterated at Cantor Fitzgerald
www.americanbankingnews.com - November 28 at 11:20 AM
Free Research Reports on These Healthcare Stocks -- Sanofi, DURECT, Sucampo Pharma, and Perrigo - PR Newswire (press release)Free Research Reports on These Healthcare Stocks -- Sanofi, DURECT, Sucampo Pharma, and Perrigo - PR Newswire (press release)
www.prnewswire.com - November 28 at 10:38 AM
Perrigo (PRGO) Launches of AB Rated Generic Version of Exalgo 32mg Extended Release Tablets - StreetInsider.comPerrigo (PRGO) Launches of AB Rated Generic Version of Exalgo 32mg Extended Release Tablets - StreetInsider.com
www.streetinsider.com - November 28 at 10:38 AM
$1.24 Billion in Sales Expected for Perrigo Company plc (PRGO) This Quarter$1.24 Billion in Sales Expected for Perrigo Company plc (PRGO) This Quarter
www.americanbankingnews.com - November 24 at 2:14 AM
Global RX-to-OTC Switching Market Current and Future Trends Report 2017 Featuring Teva, Novartis, Bayer, Mylan, GSK, Perrigo, Valeant, Grifols & MallinckrodtGlobal RX-to-OTC Switching Market Current and Future Trends Report 2017 Featuring Teva, Novartis, Bayer, Mylan, GSK, Perrigo, Valeant, Grifols & Mallinckrodt
www.prnewswire.com - November 23 at 3:09 PM
Zacks: Analysts Anticipate Perrigo Company (PRGO) to Post $1.23 EPSZacks: Analysts Anticipate Perrigo Company (PRGO) to Post $1.23 EPS
www.americanbankingnews.com - November 22 at 11:08 PM
Perrigo Co. Plc breached its 50 day moving average in a Bearish Manner : PRGO-US : November 21, 2017Perrigo Co. Plc breached its 50 day moving average in a Bearish Manner : PRGO-US : November 21, 2017
finance.yahoo.com - November 21 at 9:32 AM

SEC Filings

Perrigo (NYSE:PRGO) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Perrigo (NYSE:PRGO) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Perrigo (NYSE PRGO) Stock Chart for Friday, January, 19, 2018

Loading chart…

This page was last updated on 1/19/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.